Discontinuation report ANACIN
| Report ID | 189549 |
| Drug Identification Number | 02332450 |
| Brand name | ANACIN |
| Common or Proper name | Anacin |
| Company Name | PALADIN LABS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | CAFFEINE ACETYLSALICYLIC ACID |
| Strength(s) | 32MG 325MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 200 tablets |
| ATC code | N02BA |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | 2023-04-15 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-04-13 | French | Compare |
| v1 | 2023-04-13 | English | Compare |
Showing 1 to 2 of 2